Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
Lung Cancer (Amsterdam, Netherlands)
|
April 14, 2023
Indirect comparison of mobocertinib and real-world therapies for pre-treated non-small cell lung cancer with EGFR exon 20 insertion mutations
Petros Christopoulos, Thibaud Prawitz, Jin-Liern Hong, et al.
Headache
|
July 19, 2011
Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS)
Michael Stokes, Werner J Becker, Richard B Lipton, et al.
Immunotherapy
|
November 24, 2020
Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma: matching-adjusted indirect comparison
Philippe Moreau, Benjamin Hebraud, Thierry Facon, et al.
Targeted Oncology
|
November 3, 2025
Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study
Rachel E Sanborn, Caicun Zhou, Ke-Jing Tang, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
Lung Cancer (Amsterdam, Netherlands)
|
April 14, 2023
Indirect comparison of mobocertinib and real-world therapies for pre-treated non-small cell lung cancer with EGFR exon 20 insertion mutations
Petros Christopoulos, Thibaud Prawitz, Jin-Liern Hong, et al.
Headache
|
July 19, 2011
Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS)
Michael Stokes, Werner J Becker, Richard B Lipton, et al.
Immunotherapy
|
November 24, 2020
Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma: matching-adjusted indirect comparison
Philippe Moreau, Benjamin Hebraud, Thierry Facon, et al.
Targeted Oncology
|
November 3, 2025
Amivantamab-Chemotherapy in Non-Small Cell Lung Cancer with EGFR Exon 20 Insertions: Impact of Treatment Crossover and Other Endpoints from the Phase III PAPILLON Study
Rachel E Sanborn, Caicun Zhou, Ke-Jing Tang, et al.
Page
of 4